Andy Manar
- Democratic
Primary
Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for prescription drugs through the use of a drug formulary that are amended, delivered, issued, or renewed in the State on or after January 1, 2021 shall immediately substitute the brand name drug with the generic equivalent or move the brand name drug to a formulary tier that reduces an enrollee's cost. Grants rulemaking authority to the Department of Insurance. Defines "brand name drug", "generic drug", and "formulary". Effective January 1, 2021.
No votes to display
Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020
Rule 2-10 Third Reading/Passage Deadline Established As May 29, 2020
Rule 2-10 Committee Deadline Established As May 22, 2020
Rule 2-10 Committee Deadline Established As May 15, 2020
Rule 2-10 Third Reading/Passage Deadline Established As May 22, 2020
Rule 2-10 Committee Deadline Established As May 7, 2020
Rule 2-10 Third Reading/Passage Deadline Established As May 15, 2020
Rule 2-10 Committee Deadline Established As April 30, 2020
Pursuant to Senate Rule 3-9(b) / Referred to Assignments
Rule 2-10 Third Reading/Passage Deadline Established As May 7, 2020
Rule 2-10 Committee Deadline Established As April 24, 2020
Rule 2-10 Committee Deadline Established As April 2, 2020
Assigned to Insurance
Added as Chief Co-Sponsor Sen. Melinda Bush
First Reading
Referred to Assignments
Filed with Secretary by Sen. Andy Manar
| Bill Text Versions | Format |
|---|---|
| Introduced | HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.